Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis.
Lenalidomide, Dexamethasone and MEDI-551 in Untreated Multiple Myeloma
Higher Relative Risk for Multiple Sclerosis in a Pediatric and Adolescent Diabetes Population: Analysis From DPV Data Base.
Serum pharmacokinetics and cerebrospinal fluid concentration analysis of the new IgG4 monoclonal antibody GNbAC1 to treat multiple sclerosis: a Phase 1 study.
Clinical overview of the seizure risk of dalfampridine.
Cutaneous and pulmonary sarcoidosis following treatment of multiple sclerosis with interferon-beta-1b: a case report.
Generic Midamor
Brain gadolinium enhancement along the ventricular and leptomeningeal regions in patients with aquaporin-4 antibodies in cerebral spinal fluid.
Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis.
Long-term effects of dalfampridine in patients with multiple sclerosis.
"Undiagnosing" multiple sclerosis: The challenge of misdiagnosis in MS.
Inhibition of glycerophosphate-dependent H2O2 generation in brown fat mitochondria by idebenone.
Cranial neuropathies in multiple sclerosis defined by magnetic resonance imaging and fludeoxyglucose f 18 positron emission tomography.
LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex.
HERV-W envelope protein inhibits oligodendroglial precursor cell differentiation.
Clinical and immunological follow-up of B-cell depleting therapy in CNS demyelinating diseases.
Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.
The Many Facets of Cell Injury: Angiogenesis to Autophagy.
Rehabilitation interventions in multiple sclerosis: an overview.
Rituximab: Don't Count It Out as MS Treatment
Acorda Therapeutics announces top line results of post-marketing commitment study exploring 5 mg dose of dalfampridine-ER
[Plasmapheresis in central nervous system disorders].
Receptos Reports Positive Phase 2 Results for RPC1063 in Relapsing Multiple Sclerosis
The Impact of Lesion In-Painting and Registration Methods on Voxel-Based Morphometry in Detecting Regional Cerebral Gray Matter Atrophy in Multiple Sclerosis.
Multiple sclerosis.

Pages